Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital

We investigated the antibiotic susceptibility of glycopeptide-resistant enterococci (GRE). Seventy consecutive GRE were tested. Sixty-two isolates were identified as Enterococcus faecium (88.6%), and 8 (11.4%) as Enterococcus faecalis. All strains were susceptible to linezolid and daptomycin, while...

Descripción completa

Detalles Bibliográficos
Autores principales: Maraki, Sofia, Samonis, George, Dimopoulou, Dimitra, Mantadakis, Elpis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2014
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285005/
https://www.ncbi.nlm.nih.gov/pubmed/25566405
http://dx.doi.org/10.3947/ic.2014.46.4.253
_version_ 1782351507654443008
author Maraki, Sofia
Samonis, George
Dimopoulou, Dimitra
Mantadakis, Elpis
author_facet Maraki, Sofia
Samonis, George
Dimopoulou, Dimitra
Mantadakis, Elpis
author_sort Maraki, Sofia
collection PubMed
description We investigated the antibiotic susceptibility of glycopeptide-resistant enterococci (GRE). Seventy consecutive GRE were tested. Sixty-two isolates were identified as Enterococcus faecium (88.6%), and 8 (11.4%) as Enterococcus faecalis. All strains were susceptible to linezolid and daptomycin, while 17.1% (12/70) and 11.4% (8/70) were resistant to quinupristin/dalfopristin (QD) and tigecycline, respectively. All E. faecalis isolates were resistant to QD, while 4 of 62 (6.5%) E. faecium isolates were resistant to QD. All E. faecalis isolates were susceptible to tigecycline, while 14.5% (9/62) E. faecium isolates were resistant. Continued surveillance of GRE antibiotic susceptibilities is important for combating these multi-resistant nosocomial pathogens.
format Online
Article
Text
id pubmed-4285005
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
record_format MEDLINE/PubMed
spelling pubmed-42850052015-01-06 Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital Maraki, Sofia Samonis, George Dimopoulou, Dimitra Mantadakis, Elpis Infect Chemother Brief Communication We investigated the antibiotic susceptibility of glycopeptide-resistant enterococci (GRE). Seventy consecutive GRE were tested. Sixty-two isolates were identified as Enterococcus faecium (88.6%), and 8 (11.4%) as Enterococcus faecalis. All strains were susceptible to linezolid and daptomycin, while 17.1% (12/70) and 11.4% (8/70) were resistant to quinupristin/dalfopristin (QD) and tigecycline, respectively. All E. faecalis isolates were resistant to QD, while 4 of 62 (6.5%) E. faecium isolates were resistant to QD. All E. faecalis isolates were susceptible to tigecycline, while 14.5% (9/62) E. faecium isolates were resistant. Continued surveillance of GRE antibiotic susceptibilities is important for combating these multi-resistant nosocomial pathogens. The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2014-12 2014-12-29 /pmc/articles/PMC4285005/ /pubmed/25566405 http://dx.doi.org/10.3947/ic.2014.46.4.253 Text en Copyright © 2014 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Maraki, Sofia
Samonis, George
Dimopoulou, Dimitra
Mantadakis, Elpis
Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
title Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
title_full Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
title_fullStr Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
title_full_unstemmed Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
title_short Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
title_sort susceptibility of glycopeptide-resistant enterococci to linezolid, quinupristin/dalfopristin, tigecycline and daptomycin in a tertiary greek hospital
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285005/
https://www.ncbi.nlm.nih.gov/pubmed/25566405
http://dx.doi.org/10.3947/ic.2014.46.4.253
work_keys_str_mv AT marakisofia susceptibilityofglycopeptideresistantenterococcitolinezolidquinupristindalfopristintigecyclineanddaptomycininatertiarygreekhospital
AT samonisgeorge susceptibilityofglycopeptideresistantenterococcitolinezolidquinupristindalfopristintigecyclineanddaptomycininatertiarygreekhospital
AT dimopouloudimitra susceptibilityofglycopeptideresistantenterococcitolinezolidquinupristindalfopristintigecyclineanddaptomycininatertiarygreekhospital
AT mantadakiselpis susceptibilityofglycopeptideresistantenterococcitolinezolidquinupristindalfopristintigecyclineanddaptomycininatertiarygreekhospital

Ejemplares similares